Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4001)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2021 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fouad M, El Kassas M, Ahmed E, El Sheemy R. Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients. World J Hepatol 2021; 13(11): 1743-1752 [PMID: 34904042 DOI: 10.4254/wjh.v13.i11.1743] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i11/1743.htm |
| Number | Citing Articles |
| 1 |
Mohamed Elgazzar, Tary Salman, Eman Abdelsameea, Mohamed Akl, Nabil Omar, Mohamed Abdel-Samiee, Shrif Abas, Mohmoud Elsakhawy, Ahmed Elsherif, Ibrahim Abdelkader, Dina Elazab, Nermine Ehsan, Mohamed Mohamady, Mohamed El-Kassas, Hazem Metwaly Omar. Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01249-4
|
| 2 |
Nahed A Makhlouf, Ahmed Abu-Elfatth, Tasneem Khaled, Mohamed El-Kassas. The Interplay Between Schistosomiasis and Hepatitis C Virus: Battling on Two Fronts. Infectious Diseases & Immunity 2024; 4(4): 187 doi: 10.1097/ID9.0000000000000137
|
| 3 |
Iman Ibrahim Salama, Hala M Raslan, Ghada A Abdel-Latif, Somaia I Salama, Samia M Sami, Fatma A Shaaban, Aida M Abdelmohsen, Walaa A Fouad. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection. World Journal of Hepatology 2022; 14(6): 1053-1073 doi: 10.4254/wjh.v14.i6.1053
|
| 4 |
Kazuto Tajiri, Hiroyuki Ito, Kengo Kawai, Yoshiro Kashii, Yuka Hayashi, Aiko Murayama, Masami Minemura, Terumi Takahara, Yukihiro Shimizu, Ichiro Yasuda. Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma. World Journal of Hepatology 2022; 14(6): 1190-1199 doi: 10.4254/wjh.v14.i6.1190
|
| 5 |
Kelley G. Núñez, Tyler Sandow, Jai Patel, Mina Hibino, Daniel Fort, Ari J. Cohen, Paul Thevenot. Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates. Cancers 2022; 14(7): 1684 doi: 10.3390/cancers14071684
|
| 6 |
Agnieszka Lembas, Andrzej Załęski, Tomasz Mikuła, Joanna Jabłońska, Szymon Barczak, Barbara Badura, Alicja Wiercińska-Drapało. Differences in the course of hepatocellular carcinoma depending on the DAA treatment. Prospects in Pharmaceutical Sciences 2024; 22(3): 114 doi: 10.56782/pps.236
|